Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim was to formulate practice guidelines for management of osteoporosis in men. EVIDENCE: We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe the strength of recommendations and evidence quality. CONSENSUS PROCESS: Consensus was guided by systematic evidence reviews, one in-person meeting, and multiple conference calls and e-mails. Task Force drafts were reviewed successively by The Endocrine Society's Clinical Guidelines Subcommittee and Clinical Affairs Core Committee; representatives of ASBMR, ECTS, ESE, ISCD; and members at large. At each stage, the Task Force received written comments and incorporated needed changes. The reviewed document was approved by The Endocrine Society Council before submission for peer review. CONCLUSIONS: Osteoporosis in men causes significant morbidity and mortality. We recommend testing higher risk men [aged ≥70 and men aged 50-69 who have risk factors (e.g. low body weight, prior fracture as an adult, smoking, etc.)] using central dual-energy x-ray absorptiometry. Laboratory testing should be done to detect contributing causes. Adequate calcium and vitamin D and weight-bearing exercise should be encouraged; smoking and excessive alcohol should be avoided. Pharmacological treatment is recommended for men aged 50 or older who have had spine or hip fractures, those with T-scores of -2.5 or below, and men at high risk of fracture based on low bone mineral density and/or clinical risk factors. Treatment should be monitored with serial dual-energy x-ray absorptiometry testing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Laboratory testing is indicated to exclude secondary causes of osteoporosis [1, 14, 17] (Table 4).”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [17]
In the citing paper
“The Endocrine Society recommended that men with high fracture risk should receive an agent with proven antifracture activity irrespective of receiving testosterone or not (50).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [50]
Citations
Cites
Items 201–213 of 213
Finkelstein, J. S., Klibanski, A., & Neer, R. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.6011-2a · Cited by 24
Self-citationUnderstanding the Bone Mass Measurement Act
Watts, N. B. (1999) · Journal of Clinical Densitometry · doi:10.1385/jcd:2:3:211 · Cited by 22
Self-citationRelative contributions of multiple determinants to bone mineral density in men
Chiu, G. R., de Araújo, A. B., Travison, T. G., Hall, S. A., & McKinlay, J. B. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0895-0 · Cited by 21
Finkelstein, J. S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.9.3400-a · Cited by 20
Self-citationAmin, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00028-6 · Cited by 15
Effect of Female Database Use for T-score Derivation in Men
Wiemann, L. M., Vallarta-Ast, N., Krueger, D. C., & Binkley, N. (2007) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2007.04.001 · Cited by 14
Dual Energy X-Ray Absorptiometry (DXA)
Whitehouse, R. W. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2422-1_5 · Cited by 9
Changes in Bone Size and Geometry with Aging
Szulc, P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00016-x · Cited by 9
Dual-Energy X-ray Absorptiometry (DXA) in Men
Binkley, N., & Adler, R. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00043-2 · Cited by 7
Self-citationAge-related Changes in Bone Remodeling and Microarchitecture
Zebaze, R., & Seeman, E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00013-4 · Cited by 7
Lin, D. W., Marks, L. S., Morton, R. A., et al. (2009) · The Journal of Urology · doi:10.1016/s0022-5347(09)60653-4 · Cited by 6
Parathyroid Function in the Normal Aging Process
Khosla, S., Melton, L. J., & Riggs, B. L. (2001) · Elsevier eBooks · doi:10.1016/b978-012098651-4/50055-9 · Cited by 5
Diagnostic Thresholds for Osteoporosis in Men
Kanis, J. А., McCloskey, E. V., Johansson, H., & Odén, A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00049-3 · Cited by 4
Research works printed but not linked: 4
- Rao, 1996, Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders, 306
- Siegel, 1995, Metabolic bone diseases and disorders of the gastrointestinal tract, 113
- Barragry, 1978, Intestinal cholecalciferol absorption in the elderly and in young subjects., Clin Sci Mol Med, 55, 213
- Finkelstein, 2008, Toward a physiologically-based definition of hypogonadism in men: dose-response relationship between testosterone and bone resorption (Abstract 1102). ASBMR 30th Annual Meeting 1001–1300., J Bone Miner Res, 23, S2
Cited by
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736
The clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
UK clinical guideline for the prevention and treatment of osteoporosis
The National Osteoporosis Guideline Group (NOGG), Compston, J., Cooper, A., Cooper, C., Gittoes, N., Gregson, C., Harvey, N., Hope, S., Kanis, J. A., McCloskey, E. V., et al. (2017) · Archives of Osteoporosis · doi:10.1007/s11657-017-0324-5 · Cited by 826
Ensrud, K. E., & Crandall, C. J. (2017) · Annals of Internal Medicine · doi:10.7326/aitc201708010 · Cited by 726
Metadata
- Authors
- Watts, N. B., Adler, R. A., Bilezikian, J. P., Drake, M. T., Eastell, R., Orwoll, E. S., & Finkelstein, J. S.
- Affiliations
- Mercy Health (US)
- Virginia Commonwealth University (US)
- Columbia University (US)
- Mayo Clinic (US)
- University of Sheffield (GB)
- Oregon Health & Science University (US)
- Harvard University (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-06-01
- Volume
- 97
- Issue
- 6
- Pages
- 1802-1822
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2075195284
- Cited by
- 611
- References
- 213
- Citations by year
- 2026: 38 · 2025: 42 · 2024: 32 · 2023: 46 · 2022: 53 · 2021: 41 · 2020: 49 · 2019: 36 · 2018: 48 · 2017: 39 · 2016: 42 · 2015: 31 · 2014: 50 · 2013: 51 · 2012: 11
- FWCI
- 48.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- male osteoporosis, osteoporosis management, fracture risk assessment, dual-energy X-ray absorptiometry, bone mineral density, calcium and vitamin D supplementation, weight-bearing exercise, smoking, alcohol consumption, T-score, osteopenia, older men
- MeSH terms
- Aged, Endocrinology, Humans, Male, Middle Aged, Osteoporosis, Risk Factors, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.